Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC.
Liu C, Chen Y, Li X, Bai Z, Jiang M, Sheng D, Zou W, Huang R, Huang Q, Wang F, Zhu J, Sun H, Liu B, Li Z, Sun B.
Liu C, et al. Among authors: zhu j.
Cancer Immunol Immunother. 2025 Feb 1;74(3):80. doi: 10.1007/s00262-024-03935-8.
Cancer Immunol Immunother. 2025.
PMID: 39891774